Optimal personalised treatment computation through in silico clinical trials on patient digital twins
In Silico Clinical Trials (ISTC), i.e., clinical experimental campaigns carried out by means of computer simulations, hold the promise to decrease time and cost for the safety and efficacy assessment of pharmacological treatments, reduce the need for animal and human testing, and enable precision medicine. In this paper we present methods and an algorithm that, by means of extensive computer simulation--based experimental campaigns (ISTC) guided by intelligent search, optimise a pharmacological treatment for an individual patient (precision medicine). e show the effectiveness of our approach on a case study involving a real pharmacological treatment, namely the downregulation phase of a complex clinical protocol for assisted reproduction in humans.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Personalised Insulin Adjustment with Reinforcement Learning: An In-Silico Validation for People with Diabetes on Intensive Insulin Treatment
Despite recent advances in insulin preparations and technology, adjusting insulin remains an ongoing challenge for the majority of people with type 1 diabetes (T1D) and longstanding type 2 diabetes (T2D). In this study, …
Identify treatment effect patterns for personalised decisions
In personalised decision making, evidence is required to determine whether an action (treatment) is suitable for an individual. Such evidence can be obtained by modelling treatment effect heterogeneity in subgroups. The …
Decision MakingEfficient Real-world Testing of Causal Decision Making via Bayesian Experimental Design for Contextual Optimisation
The real-world testing of decisions made using causal machine learning models is an essential prerequisite for their successful application. We focus on evaluating and improving contextual treatment assignment decisions:…
Decision MakingExperimental DesignEvaluation of the efficacy of RUTI and ID93/GLA-SE vaccines in tuberculosis treatment: in silico trial through UISS-TB simulator
Tuberculosis (TB) is one of the deadliest diseases worldwide, with 1,5 million fatalities every year along with potential devastating effects on society, families and individuals. To address this alarming burden, vaccine…
Optimizing chemoradiotherapy for malignant gliomas: a validated mathematical approach
Malignant gliomas (MGs), particularly glioblastoma, are among the most aggressive brain tumors, with limited treatment options and a poor prognosis. Maximal safe resection and the so-called Stupp protocol are the standar…
Prognosis